314 Chapter 12 Table 7: Kinovea metrics for each of the seven surgical steps defined in the PROTEST assessment method RARP step Number of videos in which Kinovea data was available Median speed (cm/s) (min - max) Median time analysed (seconds) (min - max) Median phase duration (seconds) (min - max) Median percentage of phase analysed (%) (min - max) Pelvic floor muscle exposure RIGHT 11 2.61 (1.69 – 3.54) 9.12 (4.52 – 80.96) 63 (35-202) 18.38 (4.04 – 72.59) Pelvic floor muscle exposure LEFT 7 2.88 (1.93 – 3.28) 18.56 (3.56 – 44.64) 90 (25-138) 26.11 (5.93- 51.31) Pelvic floor muscle exposure COMBINED 7 2.68 (1.88 – 3.41) 36.40 (12.12 – 125.6) 146 (60 – 289) 24.53 (9.23 – 43.46) Bladder neck dissection 12 1.89 (1.46 – 2.28) 207.78 (99.44 – 382.40) 447 (286 – 1044) 41.14 (23.49 – 62.06) Ligation of prostatic pedicles RIGHT 12 2.07 (1.38 – 3.28) 28.48 (18.84 – 73.12) 188 (74 – 435) 16.60 (9.88 – 38.89) Ligation of prostatic pedicles LEFT 11 1.71 (0.95 – 3.25) 21.92 (5.92 – 50.40) 143 (53 – 370) 15.77 (4.14 – 31.27) Ligation of prostatic pedicles COMBINED 11 1.81 (1.26 – 3.00) 59.84 (26.00 – 93.36) 281 (222 – 805) 15.60 (7.67 – 29.99) Nerve preservation RIGHT 9 2.18 (1.17 – 2.47) 19.20 (4.04 – 72.16) 113 (46 – 600) 12.03 (5.38 – 61.48) Nerve preservation LEFT 7 1.51 (1.42 – 1.93) 20.92 (2.88 – 45.56) 190 (89 – 603) 8.72 (3.24 – 21.90) Nerve preservation COMBINED 6 1.84 (1.29 – 1.96) 52.34 (15.60 – 96.48) 337 (228 – 764) 11.82 (6.61 – 16.68) Management of prostatic apex/urethra 12 1.83 (1.17 – 2.79) 125.62 (14.52 – 281.64) 438 (211 – 1070) 28.63 (6.88 – 38.87)
RkJQdWJsaXNoZXIy MTk4NDMw